Follicular lymphoma trials in France

In France 24 Also abroad 188

24 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Where
Grenoble Cedex 9, Montpellier Cedex 5, Pessac, Rennes Cedex 9, Tours Cedex 9
Age
18 years and over
People
130 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00
Phase 1/2Taking people
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Where
Clermont-Ferrand, Dijon, Montpellier Cedex 5, Nice, Paris
Age
18 years and over
People
280 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00
Phase 2/3Taking people
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Where
Dijon, Tours Cedex 9
Age
18 years and over
People
960 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07634471 · EU 2025-522777-10-00
Phase 1Taking people
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Where
Lille, Paris
Age
18 years and over
People
215 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07101328 · EU 2025-524180-20-00
Phase 1Taking people
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Where
Nantes, Paris, Pessac, Pierre-Bénite, Toulouse Cedex 9
Age
18 years and over
People
460 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00
Phase 1Taking people
A Study of ARC-02 in B-cell NHL
Where
Creteil Cedex, Lille, Nantes, Pierre-Bénite, Villejuif Cedex
Age
18 years and over
People
140 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00
Phase 3Taking people
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Where
Bayonne, Creteil Cedex, Grenoble Cedex 9, Lille Cedex, Montpellier Cedex 5, Rennes Cedex 9, Saint-Cloud, Vandoeuvre Les Nancy
Age
18 years to 130 years
People
1,018 worldwide
Run by
AstraZeneca
See details and how to joinNCT06549595 · EU 2023-510098-33-01
Phase 2Taking people
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Where
Montpellier Cedex 5, Paris Cedex 10, Pierre-Bénite, Rouen Cedex
Age
18 years and over
People
270 worldwide
Run by
AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00
Phase 3Taking people
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Where
Argenteuil Cedex, Avignon, Bobigny Cedex, Bordeaux Cedex, Chambéry, Lomme Cedex, Marseille, Montpellier Cedex 5, Nantes, Paris, Pessac, Rennes, Rouen, Saint-Cloud, Tours Cedex 9, Villejuif
Age
18 years and over
People
580 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06149286 · EU 2022-503092-28-00
Phase 3Taking people
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Where
Angers, Argenteuil, Marseille, Nantes, Paris, Poitiers, Rennes, Strasbourg, Tours, Villejuif
Age
18 years and over
People
822 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06091254 · EU 2022-502660-20-00
Phase 1/2Taking people
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Where
Bordeaux, ClermontFerrand, Créteil, Lille, Lyon, Marseille, Montpellier, Paris, Rouen
Age
18 years and over
People
689 worldwide
Run by
BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00
Phase 1/2Taking people
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Where
Pessac, Villejuif
Age
18 years and over
People
174 worldwide
Run by
AstraZeneca
See details and how to joinNCT06542250
Phase 2Not yet taking people in France
Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy
Where
Créteil, Dijon, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Toulouse, Vandœuvre-lès-Nancy
Age
18 years and over
People
55
Run by
The Lymphoma Academic Research Organisation
See details and how to joinNCT07814001
Phase 1Taking people
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Where
Bordeaux, Marseille, Nantes
Age
18 years and over
People
85 worldwide
Run by
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT06980116 · EU 2024-516869-36-00
Phase 1Taking people
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Where
Angers, Bobigny, Nantes, Pessac, Poitiers, Saint-Cloud, Vandœuvre-lès-Nancy
Age
18 years and over
People
572 worldwide
Run by
Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00
No phaseTaking people
Evaluation of Skin Tests in Biotherapy Allergies
Where
Angers
Age
18 years and over
People
70
Run by
University Hospital, Angers
See details and how to joinNCT06971848
Phase 2Taking people
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Where
Creteil Cedex, Lille Cedex, Marseille, Nantes, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Toulouse Cedex 9, Vandoeuvre Les Nancy
Age
18 years to 70 years
People
213 worldwide
Run by
Miltenyi Biomedicine GmbH
See details and how to joinNCT04844866 · EU 2023-506270-13-00
No phaseTaking people
Long-term Ovarian Fertility in Patients Treated for Lymphoma.
Where
Lille
Age
18 years to 45 years
People
270
Run by
University Hospital, Lille
See details and how to joinNCT05616325
Phase 3Taking people
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Where
Lille Cedex, Montpellier, Nantes, Paris, Pessac, Pierre-Bénite, Saint-Cloud, Toulouse Cedex 9
Age
18 years and over
People
400 worldwide
Run by
Celgene
See details and how to joinNCT06911502 · EU 2024-519152-82-00
Phase 4Taking people
ETCABio - Evaluation of Skin Tests in Biotherapy Allergies
Where
Angers
Age
18 years and over
People
140
Run by
Centre Hospitalier Universitaire D'Angers
See details and how to join2024-519812-15-00 · EU 2024-519812-15-00
Phase 1Taking people
Study of SGR-1505 in Mature B-Cell Neoplasms
Where
Creteil Cedex, Villejuif
Age
18 years and over
People
98 worldwide
Run by
Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00
No phaseTaking people
Hypnosis: a Path to Appeasement
Where
Lyon
Age
18 years and over
People
50
Run by
Hospices Civils de Lyon
See details and how to joinNCT05942885
No phaseTaking people
MOLyF : Bone Marrow and Follicular Lymphoma
Where
Rennes
Age
18 years and over
People
200
Run by
Rennes University Hospital
See details and how to joinNCT06608147
No phaseTaking people
REal World Data in LYmphoma and Survival in Adults
Where
Arras, Besançon, Bordeaux, Bourgoin, Caen, Chambéry, Clermont-Ferrand, Créteil, Dijon, Dunkirk, Grenoble, La Roche-sur-Yon, La Tronche, Le Mans, Libourne, Lille, Limoges, Lyon, Montpellier, Mulhouse, Nantes, Niort, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Roubaix, Rouen, Saint-Brieuc, Saint-Cloud, Saint-Priest-en-Jarez, Strasbourg, Toulouse, Vannes
Age
18 years and over
People
6,000
Run by
Hospices Civils de Lyon
See details and how to joinNCT03869619